S22I (p.Ser22Ile) variant of ASH1L (Q9NR48)
S22I (p.Ser22Ile) in ASH1L (Q9NR48) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
S22I (p.Ser22Ile) variant details
- p.Ser22Ile
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.